Kiniksa Pharmaceuticals International, plc (KNSA) Revenue 2021–2025
Kiniksa Pharmaceuticals International, plc (KNSA) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$677.6MFY2025 · since FY2021: $38.5M → $677.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $677.6M | +60.1% |
| FY2024 | $423.2M | +56.6% |
| FY2023 | $270.3M | +22.7% |
| FY2022 | $220.2M | +471.2% |
| FY2021 | $38.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice